Imidazopyridine compounds inhibit mycobacterial growth by depleting ATP levels. (Q52597961)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

title

Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Theresa O'Malley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Torey Alling

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Julie V Early

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Anuradha Kumar

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Garrett C Moraski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Marvin J Miller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Thierry Masquelin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Philip A Hipskind

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Tanya Parish

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

language of work or name

English

0 references

publication date

25 May 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial Agents and Chemotherapy

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents

22 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Arrival of Imidazo[2,1-b]thiazole-5-carboxamides: Potent Anti-tuberculosis Agents That Target QcrB.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Imidazo[1,2-a]Pyridine-3-Carboxamides Are Active Antimicrobial Agents against Mycobacterium avium Infection In Vivo

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Putting Tuberculosis (TB) To Rest: Transformation of the Sleep Aid, Ambien, and "Anagrams" Generated Potent Antituberculosis Agents

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Bactericidal activity of an imidazo[1, 2-a]pyridine using a mouse M. tuberculosis infection model

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Whole cell screen for inhibitors of pH homeostasis in Mycobacterium tuberculosis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and Nanomolar Activity Against Mycobacterium tuberculosis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Efflux Attenuates the Antibacterial Activity of Q203 in Mycobacterium tuberculosis

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5971599

Synergy, antagonism, and what the chequerboard puts between them

13 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29632008

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.02439-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

PubMed publication ID

29632008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29632008%20AND%20SRC:MED&resulttype=core&format=json